{
    "2021-12-06": [
        [
            {
                "time": "",
                "original_text": "北向资金连续4日净买入累计加仓超150亿，大幅抢筹券商、银行股",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净买入",
                        "加仓",
                        "券商",
                        "银行股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "券商",
                        "银行"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "2021年基金，买了个“寂寞”",
                "features": {
                    "keywords": [
                        "基金",
                        "2021年",
                        "投资回报"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "粤开策略深度 | 医药生物行业2022年展望：价值重鸣，创新为锋",
                "features": {
                    "keywords": [
                        "医药生物",
                        "2022年",
                        "价值重鸣",
                        "创新"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：医保谈判落地 释放积极信号",
                "features": {
                    "keywords": [
                        "医药生物",
                        "医保谈判",
                        "积极信号"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "智飞生物新冠疫苗价值受关注 三季报增长股价反跌有何玄机？",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "新冠疫苗",
                        "三季报",
                        "增长",
                        "股价反跌"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}